In patients with implantable cardiac electronic devices, SGLT2 inhibitors reduced the risk of atrial arrhythmias by about a quarter. This is most likely due to SGLT2 inhibitors switching on AMPK which reduces atrial enlargement and scar formation. What do you think?
SGLT2 Inhibitors Tied to Fewer Atrial Arrhythmias
SGLT2 Inhibitors Tied to Fewer Atrial Arrhythmias
SGLT2 Inhibitors Tied to Fewer Atrial Arrhythmias
In patients with implantable cardiac electronic devices, SGLT2 inhibitors reduced the risk of atrial arrhythmias by about a quarter. This is most likely due to SGLT2 inhibitors switching on AMPK which reduces atrial enlargement and scar formation. What do you think?